Your browser doesn't support javascript.
loading
Author Correction: Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia.
Inano, Tadaaki; Araki, Marito; Morishita, Soji; Imai, Misa; Kihara, Yoshihiko; Okuda, Maho; Yang, Yinjie; Ito, Masafumi; Osaga, Satoshi; Mano, Hiroyuki; Edahiro, Yoko; Ochiai, Tomonori; Misawa, Kyohei; Fukuda, Yasutaka; Ando, Jun; Komatsu, Norio.
Affiliation
  • Inano T; Department of Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Araki M; Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Morishita S; Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Imai M; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Kihara Y; Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Okuda M; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Yang Y; Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Ito M; Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Osaga S; Leading Center for the Development and Research of Cancer Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Mano H; Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Edahiro Y; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Ochiai T; Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Tomioka, Urayasu-city, Chiba, 279-0021, Japan.
  • Misawa K; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Fukuda Y; Department of Pathology, Japanese Red Cross Nagoya First Hospital, Aichi, Japan.
  • Ando J; Clinical Research Management Center, Nagoya City University Hospital, Aichi, Japan.
  • Komatsu N; National Cancer Center Research Institute, Tokyo, Japan.
Sci Rep ; 12(1): 1115, 2022 Jan 17.
Article in En | MEDLINE | ID: mdl-35039617
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: